FTC Challenges $28B Amgen-Horizon Therapeutics Merger
The Federal Trade Commission on Tuesday sought to shut down U.S. biotechnology company Amgen Inc.'s proposed $27.8 billion purchase of Ireland-based drugmaker Horizon Therapeutics PLC, filing a lawsuit in federal court...To view the full article, register now.
Already a subscriber? Click here to view full article